The Endogenous Pathway of MHC Class II Antigen Presentation

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Immunological Reviews

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1600-065X.1996.tb00703.xPMID 8872485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of HLA-DMB mutants and -DMB genomic structure

  2004cited by this paper
• In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.

  1997cited by this paper
• The TAP complex influences allorecognition of class II MHC molecules.

  1996cited by this paper
• Association between HLA-DM and HLA-DR in vivo.

  1996cited by this paper
• Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.

  1996cited by this paper
• Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response.

  1996cited by this paper
• Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.

  1996cited by this paper
• Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

  1995cited by this paper
• Association of the Invariant Chain with Major Histocompatibility Complex Class I Molecules Directs Trafficking to Endocytic Compartments (*)

  1995cited by this paper
• Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.

  1995cited by this paper
• Processing of a viral glycoprotein in the endoplasmic reticulum for class II presentation

  1995cited by this paper
• Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain

  1995cited by this paper
• Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation.

  1995cited by this paper
• Antigen presentation. DM exchange mechanism.

  1995cited by this paper
• Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.

  1995cited by this paper
• DM exchange mechanism

  1995cited by this paper
• Antigen presentation mediated by recycling of surface HLA-DR molecules

  1995cited by this paper
• T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates

  1995cited by this paper
• Mediation by HLA-DM of dissociation of peptides from HLA-DR

  1995cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper
• Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

  1995cited by this paper
• A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

  1995cited by this paper
• The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent

  1995cited by this paper
• The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif.

  1995cited by this paper
• The primary alloresponse of human CD4+ T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression.

  1995cited by this paper
• Molecular Requirements for the Interaction of Class II Major Histocompatibility Complex Molecules and Invariant Chain with Calnexin (*)

  1995cited by this paper
• HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.

  1995cited by this paper
• Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II

  1995cited by this paper
• Transient Aggregation of Major Histocompatibility Complex Class II Chains during Assembly in Normal Spleen Cells (*)

  1995cited by this paper
• DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing.

  1995cited by this paper
• Intracellular assembly and transport of endogenous peptide-MHC class II complexes.

  1994cited by this paper
• Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments.

  1994cited by this paper
• A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides

  1994cited by this paper
• Mapping functional regions in the lumenal domain of the class II- associated invariant chain

  1994cited by this paper
• Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.

  1994cited by this paper
• An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules

  1994cited by this paper
• Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.

  1994cited by this paper
• The coated pit and macropinocytic pathways serve distinct endosome populations

  1994cited by this paper
• Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain.

  1994cited by this paper
• In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides.

  1994cited by this paper
• Retrieval of TGN proteins from the cell surface requires endosomal acidification.

  1994cited by this paper
• Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.

  1994cited by this paper
• Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses.

  1994cited by this paper
• Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells.

  1994cited by this paper
• An N‐terminal double‐arginine motif maintains type II membrane proteins in the endoplasmic reticulum.

  1994cited by this paper
• Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain.

  1994cited by this paper
• Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.

  1994cited by this paper
• The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line

  1994cited by this paper
• MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

  1994cited by this paper
• Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells.

  1994cited by this paper
• A role for calnexin (IP90) in the assembly of class II MHC molecules.

  1994cited by this paper
• Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants

  1993cited by this paper
• Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules

  1993cited by this paper
• Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.

  1993cited by this paper
• Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells.

  1993cited by this paper
• Major histocompatibility complex class II‐restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents

  1993cited by this paper
• Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression

  1993cited by this paper
• Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC.

  1993cited by this paper
• Mice lacking the MHC class II-associated invariant chain.

  1993cited by this paper
• Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization.

  1993cited by this paper
• Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.

  1993cited by this paper
• Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal

  1993cited by this paper
• Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways

  1993cited by this paper
• The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44.

  1993cited by this paper
• Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.

  1993cited by this paper
• Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

  1993cited by this paper
• Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines.

  1993cited by this paper
• Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad.

  1992cited by this paper
• Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.

  1992cited by this paper
• Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer

  1992cited by this paper
• HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides

  1992cited by this paper
• HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells

  1992cited by this paper
• The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide

  1992cited by this paper
• Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.

  1992cited by this paper
• The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide.

  1992cited by this paper
• T and B cell receptors discriminate major histocompatibility complex class II conformations influenced by the invariant chain

  1992cited by this paper
• Stable surface expression of invariant chain prevents peptide presentation by HLA‐DR.

  1992cited by this paper
• Ham-2 corrects the class I antigen-processing defect in RMA-S cells

  1992cited by this paper
• Mutations affecting antigen processing impair class II-restricted allorecognition.

  1991cited by this paper
• Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.

  1991cited by this paper
• Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.

  1991cited by this paper
• Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74).

  1991cited by this paper
• A new human HLA class II-related locus, DM

  1991cited by this paper
• Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain

  1991cited by this paper
• Sequence analysis of peptides bound to MHC class II molecules

  1991cited by this paper
• MHC class II-restricted presentation of intracellular antigen.

  1991cited by this paper
• A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex

  1991cited by this paper
• Class II‐restricted IgG2ab‐specific T cells recognize a signal‐minus form of the V‐CH3b antigen

  1991cited by this paper
• Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum.

  1990cited by this paper
• Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding

  1990cited by this paper
• Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule

  1990cited by this paper
• The structural basis of alloreactivity

  1990cited by this paper
• Intracellular transport of class II MHC molecules directed by invariant chain

  1990cited by this paper
• Class II MHC molecules can use the endogenous pathway of antigen presentation

  1990cited by this paper
• The function of the invariant chain in antigen presentation by MHC class II molecules.

  1990cited by this paper
• MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.

  1990cited by this paper
• Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways

  1990cited by this paper
• Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes

  1990cited by this paper
• Capacity of intact proteins to bind to MHC class II molecules.

  1989cited by this paper
• Antigen presentation 1

  1989cited by this paper

• Development of MHC class II-restricted TCR gene therapy for Epstein Barr virus associated malignancies

  2016cites this paper
• Assessment of the frequency of regulatory T cells (CD4+CD25+CD127−) in children with hemophilia A: relation to factor VIII inhibitors and disease severity

  2016cites this paper
• Rheumatoid Rescue of Misfolded Cellular Proteins by MHC Class II Molecules: A New Hypothesis for Autoimmune Diseases.

  2016cites this paper
• Identification et caractérisation des peptides hapténisés avec la benzylpénicilline responsables de l’activation des cellules T naïves et de l’immunisation des patients allergiques à la pénicilline

  2016cites this paper
• Immunity at the Maternal–Fetal Interface

  2015cites this paper
• Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways

  2015cites this paper
• cells in hemophilia patients with factor VIII inhibitor

  2014cites this paper
• Higher frequency of CD4(+)CD25(high) Treg cells in hemophilia patients with factor VIII inhibitor.

  2014cites this paper
• Autophagy in immunity and infection

  2014cites this paper
• Toward a Network Model of MHC Class II-Restricted Antigen Processing

  2013cites this paper
• Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

  2013cites this paper
• Central Role of Th17 Cells in Adaptive Immune Responses

  2013cites this paper
• Major Histocompatibility Complex Class II+ Invariant Chain Negative Breast Cancer Cells Present Unique Peptides that Activate Tumor-specific T Cells from Breast Cancer Patients*

  2012cites this paper
• Major Histocompatibility Complex Class II Invariant Chain Negative Breast Cancer Cells Present Unique Peptides that Activate Tumor

  2012cites this paper
• T cell immunity to Kaposi’s sarcoma-associated herpesvirus latent proteins

  2012cites this paper
• Major Histocompatibility Complex Class II (cid:1) Invariant Chain Negative Breast Cancer Cells Present Unique Peptides that Activate Tumor-specific T Cells from Breast Cancer Patients* □

  2012cites this paper
• Profiling of differentially expressed genes in haemophilia A with inhibitor

  2012cites this paper
• HLA-DR-presented Peptide Repertoires Derived From Human Monocyte-derived Dendritic Cells Pulsed With Blood Coagulation Factor VIII

  2011cites this paper
• 'Nodophagy': New crossroads in Crohn disease pathogenesis.

  2010cites this paper
• 'Nodophagy': New cross-roads in Crohn's disease pathogenesis

  2010cites this paper
• Entwicklung eines Lebend- und eines Totimpfstoffes gegen intrazelluläre Erreger auf Basis von Yersinia enterocolitica

  2010cites this paper
• ÉVALUATION DES PROTEINES MIDKINE ET SURVIVINE SUREXPRIMEES DANS LES CELLULES TUMORALES COMME CIBLES DE L'IMMUNITE CELLULAIRE ANTI-TUMORALE

  2009cites this paper
• Impact of major histocompatibility complex class II polymorphisms on Iberian red deer parasitism and life history traits.

  2009cites this paper
• Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells

  2009cites this paper
• Infection of HLA-DR1 Transgenic Mice with a Human Isolate of Influenza A Virus (H1N1) Primes a Diverse CD4 T-Cell Repertoire That Includes CD4 T Cells with Heterosubtypic Cross-Reactivity to Avian (H5N1) Influenza Virus

  2009cites this paper
• Understanding the focused CD4 T cell response to antigen and pathogenic organisms

  2009influential citation
• T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display

  2009cites this paper
• MHC class II antigen loading compartments continuously receive input from autophagosomes

  2008cites this paper
• Appropriate Timing of CD40 Ligation for RNA‐Pulsed DCs to Induce Antitumor Immunity

  2008cites this paper
• Selective analysis of specific HLA ligand repertoires: poxviral CD8+ T cell epitopes and phosphorylated HLA ligands of tumor cells

  2008cites this paper
• Endogenous presentation of a nuclear antigen on MHC class II by autophagy in the absence of CRM1‐mediated nuclear export

  2008cites this paper
• EBV Latent Membrane Proteins (LMPs) 1 and 2 as Immunotherapeutic Targets: LMP-Specific CD4+ Cytotoxic T Cell Recognition of EBV-Transformed B Cell Lines1

  2008cites this paper
• LinesRecognition of EBV-Transformed B Cell Cytotoxic T Cell + LMP-Specific CD4 and 2 as Immunotherapeutic Targets: EBV Latent Membrane Proteins (LMPs) 1

  2008cites this paper
• Innate and adaptive immunity in the human female reproductive tract: influence of the menstrual cycle and menopause on the mucosal immune system in the uterus

  2008cites this paper
• Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses.

  2007cites this paper
• Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

  2007cites this paper
• Autophagy Delivers Viral Antigens for MHC Class II Presentation and is Regulated by Viral Infection

  2007cites this paper
• Antigen Presentation by Human Uterine Epithelial Cells to Autologous T Cells

  2006cites this paper
• Chaperone-mediated autophagy in aging and disease.

  2006cites this paper
• Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.

  2006cites this paper
• Microarray-based gene expression analysis for the investigation of immunologically relevant processes in tumors

  2006cites this paper
• Genetic risk factors for inhibitors to factors VIII and IX

  2006cites this paper
• Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.

  2006cites this paper
• Entwicklung eines oralen Yersinia Lebendimpfstoffes als Antigenträger: Einfluss der Yop Effektorproteine auf die Immunantwort

  2005cites this paper
• Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

  2005cites this paper
• Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome1

  2005cites this paper
• Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

  2005cites this paper
• The pleiotropic role of autophagy: from protein metabolism to bactericide

  2005cites this paper
• Capacidad adyuvante del proteoliposoma derivado de la membrana externa de Neisseria meningitidis B

  2005cites this paper
• Cell biology of antigen processing in vitro and in vivo.

  2005cites this paper
• Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

  2005cites this paper
• Tumor‐specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens

  2005cites this paper
• Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?

  2005cites this paper
• The MHC II ligandome : mass spectrometric applications in immunology

  2005cites this paper
• Chapter 95 – Mucosal Immunity in the Human Female Reproductive Tract

  2005cites this paper
• Optimization of CD4+ T Lymphocyte Response to Human Cytomegalovirus Nuclear IE1 Protein through Modifications of Both Size and Cellular Localization1

  2005cites this paper
• MHC immunoevasins: protecting the pathogen reservoir in infection.

  2005cites this paper
• Immune surveillance of intracellular pathogens via autophagy

  2005cites this paper
• Chapter 2 – MHC Class II

  2005cites this paper
• Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.

  2004cites this paper
• T cell-based therapies for EBV-associated malignancies

  2004cites this paper
• Antigen-presenting cells in rheumatoid arthritis

  2004cites this paper
• "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming.

  2004cites this paper
• Acidification Revealed in the Early Endosome by Hemagglutinin-Derived Epitope That Is Molecules of an Influenza Presentation by Recycling MHC Class II

  2003cites this paper
• Efficient generation and expansion of antigen‐specific CD4+ T cells by recombinant influenza viruses

  2003cites this paper
• Antigen presentation in graft-vs-host disease.

  2003cites this paper
• Presentation by Recycling MHC Class II Molecules of an Influenza Hemagglutinin-Derived Epitope That Is Revealed in the Early Endosome by Acidification1

  2003cites this paper
• In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker.

  2003influential citation
• Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity.

  2003cites this paper
• Attenuated Yersinia pseudotuberculosis Carrier Vaccine for Simultaneous Antigen-Specific CD4 and CD8 T-Cell Induction

  2003cites this paper
• Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy

  2003cites this paper
• The Mucosal Immune System in the Human Female Reproductive Tract: Influence of Stage of the Menstrual Cycle and Menopause on Mucosal Immunity in the Uterus

  2002cites this paper
• Infection of APC by Human Cytomegalovirus Controlled Through Recognition of Endogenous Nuclear Immediate Early Protein 1 by Specific CD4+ T Lymphocytes1

  2002cites this paper
• Selective modification of antigen-specific CD4(+) T cells by retroviral-mediated gene transfer and in vitro sensitization with dendritic cells.

  2002cites this paper
• RNA Based Vaccines

  2002cites this paper
• Diversity in MHC class II antigen presentation

  2002cites this paper
• The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.

  2002cites this paper
• Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.

  2002cites this paper
• A brief overview of the tumor vaccines through the last decade

  2002cites this paper
• T Lymphocytes + 1 by Specific CD4 Endogenous Nuclear Immediate Early Protein Controlled Through Recognition of Infection of APC by Human Cytomegalovirus

  2002cites this paper
• Immunologic approaches to the management of pancreatic cancer.

  2001cites this paper
• Efficient Presentation of Both Cytosolic and Endogenous Transmembrane Protein Antigens on MHC Class II Is Dependent on Cytoplasmic Proteolysis1

  2001cites this paper
• Cytoplasmic Proteolysis Antigens on MHC Class II Is Dependent on Endogenous Transmembrane Protein Efficient Presentation of Both Cytosolic and

  2001cites this paper
• A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.

  2000cites this paper
• Hb(64-76) epitope binds in different registers and lengths to I-Ek and I-Ak.

  2000cites this paper
• Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.

  2000cites this paper
• Development of a dendritic cell-based vaccine to enhance CD4+ T-cell responses to a breast tumour antigen

  2000influential citation
• The generation and in vitro characterisation of EBV B-LCL x melanoma hybrid cells as potential candidates in tumour immunotherapy

  2000cites this paper
• Phycobiliprotein-Fab conjugates as probes for single particle fluorescence imaging.

  2000cites this paper
• Characterization of MHC class II‐presented peptides generated from an antigen targeted to different endocytic compartments

  2000cites this paper
• Processing of bacterial antigens for peptide presentation on MHC class I molecules

  1999cites this paper
• Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis.

  1999cites this paper
• Immunotherapy: the last 25 years.

  1999cites this paper
• Antigen‐Presenting Cells in the Human Female Reproductive Tract: Analysis of Antigen Presentation in Pre‐ and Post‐Menopausal Women

  1999cites this paper
• Cell‐based vaccines for the stimulation of immunity to metastatic cancers

  1999cites this paper
• Microanatomy and Function of the Spleen

  1999cites this paper
• Differential epidermal expression of the invariant chain in allergic and irritant contact dermatitis.

  1998cites this paper
• Class II-transfected tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigens in vivo.

  1998cites this paper
• Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

  1998cites this paper
• T cells specific for a polymorphic segment of CD45 induce graft-versus-host disease with predominant pulmonary vasculitis.

  1998cites this paper